Answers are grounded in this paper and cite their sources.
Caffeine is commonly prescribed in the NICU to treat apnea of prematurity. This review is an update based on current knowledge of the mechanisms of action, pharmacologic properties, clinical effects, and safety of caffeine in the neonatal population. Recent studies of caffeine in the neonatal population confirm its efficacy in treating apnea-related symptoms and reveal additional significant benefits with minimal short-term, and no long-term, adverse effects.
No takes yet. Share an insight, caveat, or question.
Dobson et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: